Add to Calendar 3/27/2019 8:15:00 AM 3/28/2019 2:30:00 PM 2019 Annual Meeting: State of Possible Conference
This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142

This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

Vice President and Head, Clinical Science, Neuroscience Therapeutic Area Unit, Takeda
Robert (Bob) Alexander, M.D. received his undergraduate and medical degrees from the University of Chicago. He completed an internship in Internal Medicine at the New England Deaconess and a residency in Adult Psychiatry at McLean Hospital/Harvard Medical School. Following residency, Bob was a fellow at the National Institute of Mental Health (NIMH) with the late Richard Wyatt and at Columbia University (in Medical Genetics). As part of his NIMH fellowship he spent one year in the laboratory of Dr. David Sachs of the National Cancer Institute learning positional cloning and other molecular biology techniques. The focus of Bob’s fellowships and early research was in schizophrenia (including investigations into proposed etiologic causes such as the viral and autoimmune hypotheses) and genetics of psychiatric disorders (in particular, genetic animal models informative for addiction and psychosis). Bob was on the faculty of Thomas Jefferson University from 1992 to 1995 and then worked at the University of Pennsylvania, where he developed expertise in the treatment of substance abuse. During his career, Dr. Alexander has held a number of academic positions and hospital appointments and is currently a Staff Psychiatrist at McLean Hospital. Bob is currently the Vice President and Head, Clinical Science, Neuroscience Therapeutic Area Unit at Takeda. Prior to Takeda, Bob was Vice President and Head of Clinical for the Neuroscience and Pain Research Unit; Vice President, Clinical, for CNS and Pain Innovative Medicines Unit (iMed) of AstraZeneca; Vice President and Head of Discovery Medicine and Chief Medical Officer of the Neurosciences Centre for Excellence in Drug Discovery at GlaxoSmithKline; and Senior Director in Clinical Neuroscience and Clinical Pharmacology at Merck Research Labs. Bob is an expert in psychopharmacology and have conducted clinical studies in a broad range of neurologic and psychiatric and targets, including Alzheimer's disease (AD), Parkinson’s dise

Brought to you by